CNBC's Jim Goldman takes a look at how Apple's stock is reacting to news that the company's CEO had a liver transplant two months and expects to return to Apple at the end of June.
Apple: Steve Jobs' Liver Transplant
Comment
Latest Markets Videos
Video Archives
